Other short opinions/comments on moderate/low cancer genetic risk markers in medical practice and the article Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology by Lubinski et al., Breast Cancer Res Treat 2008 Apr 15

Abstract

So far, we have not performed genetic testing on moderate cancer risk, such as CHEK2 testing for breast cancer. We feel that this would lead to a large number of the population being positive and that it is unlikely that all carriers would be offered surveillance. Furthermore, the economic burden from surveillance for moderate risk may not be acceptable in… (More)
DOI: 10.1186/1897-4287-6-2-67

Topics

Cite this paper

@article{Aittomki2008OtherSO, title={Other short opinions/comments on moderate/low cancer genetic risk markers in medical practice and the article Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology by Lubinski et al., Breast Cancer Res Treat 2008 Apr 15}, author={Kristiina Aittom{\"a}ki}, journal={Hereditary Cancer in Clinical Practice}, year={2008}, volume={6}, pages={67 - 68} }